Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors.
Clinical trial NCT01248858 · TERMINATED
Trial details
- NCT number
- NCT01248858
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-03
- Primary completion
- 2014-01-30
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.